|Articles|May 1, 2017
- Pharmaceutical Executive-05-01-2017
- Volume 37
- Issue 5
Pharmaceutical Executive, May 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Brand of the Year: A Retrospectiveabout 9 years ago
Portfolio Management Health Checkabout 9 years ago
Launch for Long-Term Successabout 9 years ago
Merck’s Latest Shot Against Shinglesabout 9 years ago
Measuring the Value of Prescription Drugsabout 9 years ago
Life Sciences' Shifting Sands: 5 Trends that Threaten the Status Quoabout 9 years ago
New Life in European Drug Pricing Spatabout 9 years ago
Country Report: SwitzerlandAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5